The Global Wearable Injectors Market in terms of revenue was estimated to be worth $7.2 billion in 2021 and is poised to reach $11.5 billion by 2026, growing at a CAGR of 9.9% from 2021 to 2026. The current edition of the report consists of an updated market overview, average selling price trends, value chain analysis, Porter’s Five Forces analysis, ecosystem map, pricing analysis, patent analysis, and new industry insights. The growth of this market is primarily driven by the rising prevalence of chronic diseases (such as cancer, diabetes, and CVD), favourable reimbursement scenarios in major markets, and technological advancements in injector devices. However, high costs and a poor reimbursement structure in developing countries are expected to limit the adoption of wearable injectors to a certain extent.

wearable-injector-market-new.JPGDownload PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100771004

Key Players:

Ypsomed (Switzerland), Amgen (US), Subcuject (Denmark), Enable Injections (US), Medtronic plc (Ireland), Insulet Corporation (US), United Therapeutics Corp. (US), CeQur SA (Switzerland), Sensile Medical (Switzerland), ATS Automation (Canada), West Pharmaceutical Services, Inc. (US), Tandem Diabetes Care (US), Valeritas (US), Sonceboz (Switzerland), Noble (US), Elcam Drug Delivery Devices (Israel), Bespak Europe Ltd. (UK), Stevanato Group (Italy), Sorrel Medical (Israel), Weibel CDS AG (Switzerland), and Neuma (US).

Market Dynamics

Drivers

  • Shift of healthcare delivery toward homecare due to COVID-19
  • Advantages of wearable injectors in the administration of various drugs
  • Growing prevalence of chronic diseases
  • Favorable reimbursement scenario in major markets
  • Technological advancements and design development

 Restraints

  • Preference for alternative drug delivery modes
  • High cost of wearable injectors

Opportunities

  • Increasing demand for biologics and mAbs

 Challenges

  • Unfavorable reimbursement structure in developing countries

North America had the largest market share among players in the wearable injectors market.

North America accounted for the largest share of the global market. The large share of the region is due to the shift of healthcare delivery toward homecare due to COVID-19, the rising prevalence of chronic diseases, increasing concerns over the hazards related to the administration of conventional and novel drug molecules, a favourable reimbursement scenario, and the presence of major market players in the region.

Request 10% Customization:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=100771004

Wearable Injectors Market Segmentation:

By Type

  • On-body Injector
  • Off-body Injector

By Technology

  • Spring Based
  • Motor Based
  • Rotary pump
  • Expanding battery
  • Other technology

By Therapy

  • Immuno-oncology
  • Diabetes
  • Cardiovascular disease
  • Other disease

By End User

  • Hospitals and clinics
  • Home healthcare setting

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments:

  • In April 2021, Medtronic launched the Infusion Set that can be worn up to seven days
  • In April 2021, Amgen acquired Five Prime Therapeutics. This acquisition—for USD 38.00 per share in cash—was focused on developing immuno-oncology and targeted cancer therapies.
  • In September 2020, Insulet Corporation expanded its presence in Sweden, Finland, Norway, and Denmark.

Objectives of the Study

  • To define, describe, analyze, and forecast the size of the wearable injectors market on the basis of type, technology, therapy, end user and region.
  • To provide detailed information on the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of the market segments with respect to North America, Europe, Asia Pacific, latin America and Middle East and Africa.
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies.
  • To track and analyze competitive developments such as product launches, partnerships, acquisitions and other developments in the market.
  • To benchmark players within the wearable injectors market using the Competitive Leadership Mapping framework which analyzes market players on various parameters within the broad categories of business and product strategy.

Report Link: ( Wearable Injectors Market )

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/wearable-injector-market.asp

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/wearable-injector.asp

Related Links:

https://www.prnewswire.com/news-releases/wearable-injectors-market-worth-11-5-billion-by-2026--exclusive-report-by-marketsandmarkets-301343060.html

https://www.globenewswire.com/en/news-release/2022/12/06/2567995/0/en/Wearable-Injectors-Market-worth-11-5-billion-by-2026-Exclusive-Report-by-MarketsandMarkets.html